Andere talen Compugen Ltd.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,9 ^USD	+1,06%		-10,80%	-4,04%

08/03	COMPUGEN LTD. : Truist Securities herhaalt koopadvies	ZM
05/03	Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Compugen to Participate in Two Upcoming Investor Conferences	03/04
Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	07/03
Compugen : To Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	06/03
Compugen: Q4 Earnings Snapshot	05/03
Earnings Flash (CGEN) COMPUGEN Reports Q4 Revenue $33.5M	05/03
Earnings Flash (CGEN) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen : Form 6-K- Fourth quarter and full year 2023 results	05/03
Earnings Flash (CW9) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/03
Compugen Reports Fourth Quarter and Full Year 2023 Results	05/03
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024	26/02
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024	20/02
Compugen names new chief medical officer	16/02
Compugen Ltd. Announces Executive Changes	15/02
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer	15/02
Sector Update: Health Care Stocks Stronger Late Afternoon	19/12
Sector Update: Health Care	19/12
Looming Inflation Data Stifle US Equity Futures Pre-Bell	19/12

Geen resultaten voor deze zoekopdracht